Rule 4729:8-3-03 | Electronic format required for the transmission of drug sales.
(A) All prescription dispensing information or prescriber personally furnishing information required to be submitted to the board pursuant to rule 4729:8-3-02 of the Administrative Code must be transmitted in the following format specified by the "American Society for Automation in Pharmacy" (ASAP) for prescription monitoring programs:
(1) ASAP version 5.0 "Standard for Prescription Drug Monitoring Programs (4/1/2025)"; or
(2) Until July 1, 2026, "ASAP version 4.2A Standard for Prescription Drug Monitoring Programs" (3/15/2017).
(B) The board's executive director or the director's designee may authorize up to a six-month extension to the implementation of ASAP version 5.0 beyond July 1, 2026. Such extensions may only be considered if the pharmacy or prescriber has made all reasonable and prudent attempts to meet the deadline.
(C) In the event that a pharmacy or a prescriber cannot electronically transmit the required information pursuant to paragraph (A) of this rule, the pharmacy or prescriber may request a variance from the board's executive director or the director's designee to submit drug sales information in a mutually acceptable format.
(D) All wholesale data required to be submitted to the board of pharmacy pursuant to rule 4729:8-3-02 of the Administrative Code shall be transmitted in the report format used when transmitting controlled substance data to the federal drug enforcement administration via the "Automation of Reports and Consolidated Orders System" (ARCOS) or other mutually acceptable format.
(E) In the event that a drug distributor or terminal distributor cannot electronically transmit the required information pursuant to paragraph (D) of this rule, the drug distributor or terminal distributor may request a variance from the board's executive director or the director's designee to submit drug sales information in a mutually acceptable format.
Last updated July 1, 2026 at 9:05 AM
Supplemental Information